Advair HFA 45/21mcg Oralinh 120s
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all accompanying information carefully. This medication is for inhalation only.
Key Instructions:
Continue using this medication as directed by your doctor or healthcare provider, even if you feel well.
Take this medication at the same time every day to establish a routine.
After each use, rinse your mouth with water and spit it out - do not swallow the rinse water.
If you are using multiple inhaled medications, consult your doctor about which one to use first.
Before using the inhaler, shake it well.
Prior to the first use, prime the inhaler by spraying 4 test sprays into the air, away from your face. If the inhaler has not been used for more than 4 weeks or has been dropped, prime it again with 2 sprays into the air, away from your face, shaking well before each test spray.
Replace the cap on the inhaler after each use.
Important Safety Precautions:
This medication is flammable, so avoid using it near an open flame or while smoking.
Some inhalers have a dose counter to track the number of doses remaining. If your inhaler has a dose counter, discard it when the counter reaches "0".
Storage and Disposal:
Store this medication at room temperature in a dry place, avoiding bathrooms.
Keep the inhaler stored with the mouthpiece facing down.
Missed Dose:
If you miss a dose, skip it and return to your regular schedule.
* Do not take two doses at the same time or extra doses to make up for a missed dose.
Lifestyle & Tips
- Use Advair HFA regularly, twice a day, every day, even if you feel well. Do not stop using it without talking to your doctor.
- This is not a rescue inhaler. Always carry your fast-acting rescue inhaler (e.g., albuterol) for sudden breathing problems.
- Rinse your mouth with water and spit it out after each use of Advair HFA to help prevent a fungal infection (thrush) in your mouth and throat.
- Learn and practice proper inhaler technique as demonstrated by your healthcare provider. Incorrect technique can reduce effectiveness.
- Keep track of your symptoms and how often you use your rescue inhaler. Report any worsening symptoms to your doctor.
- Avoid your known asthma or COPD triggers (e.g., smoke, allergens, pollution).
- Do not exceed the prescribed dose. Using too much can increase side effects.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, severe dizziness or fainting, muscle weakness, fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or agitated
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Abnormal burning, numbness, or tingling sensations
Choking
Voice changes
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat
Important Warning: This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor:
Headache
Upset stomach or vomiting
Throat irritation
* Signs of a common cold
This list is not exhaustive. If you have questions about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
- Increased need for your rescue inhaler
- Chest pain or fast/pounding heartbeat (palpitations)
- Tremor or nervousness
- Signs of an allergic reaction (e.g., rash, hives, swelling of face/mouth/tongue, severe dizziness, trouble breathing)
- Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
- White patches in your mouth or throat (oral thrush)
- Vision changes (e.g., blurred vision, eye pain)
- Unusual tiredness, weakness, nausea, vomiting, or dizziness (signs of adrenal suppression)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist to determine if the medication is similar.
Any prescription or over-the-counter (OTC) medications, natural products, or vitamins you are taking that may interact with this medication. Certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
Please note that this is not an exhaustive list of all medications or health conditions that may interact with this medication.
To ensure your safety, it is crucial to discuss all of your medications (prescription or OTC, natural products, vitamins) and health conditions with your doctor and pharmacist. This will help determine if it is safe to take this medication with your existing medications and health conditions. Never start, stop, or change the dosage of any medication without first consulting your doctor.
Precautions & Cautions
It is crucial that you inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. You may not feel the full effects of this medication for approximately 1 week.
If you have diabetes (high blood sugar), consult with your doctor, as this medication may cause an increase in blood sugar levels. Monitor your breathing problems closely, and contact your doctor immediately if they worsen, if your rescue inhaler becomes less effective, or if you need to use it more frequently.
Dosage and Administration
Do not exceed the recommended dose or frequency of this medication, as overdoses have been fatal. Consult with your doctor if you have any questions or concerns.
Special Considerations
When transitioning from an oral steroid to a different form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of signs such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar, and contact your doctor immediately if you experience any of these symptoms.
In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card with you to alert healthcare providers of this potential need.
Long-term Use and Potential Side Effects
Prolonged use of this medication may increase your risk of developing cataracts or glaucoma. Consult with your doctor and schedule regular eye exams as recommended.
Long-term use may also lead to osteoporosis (weak bones). Discuss your individual risk factors with your doctor and undergo bone density tests as advised.
Infection Risk and Prevention
You may be more susceptible to infections while taking this medication. To minimize your risk, practice good hygiene by washing your hands frequently, and avoid close contact with individuals who have infections, colds, or flu.
If you have not had chickenpox or measles before, avoid exposure to these illnesses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed, consult with your doctor promptly.
Special Populations
If you are 65 years or older, use this medication with caution, as you may be more prone to side effects.
In children and adolescents, this medication may affect growth in some cases. Regular growth checks may be necessary, so consult with your doctor.
Pregnancy and Breastfeeding
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the potential benefits and risks of this medication with your doctor.
Overdose Information
Overdose Symptoms:
- Salmeterol overdose: Tachycardia, arrhythmias, tremor, headache, nausea, muscle cramps, hypokalemia, hyperglycemia.
- Fluticasone overdose (acute): Generally well-tolerated, but chronic overdose may lead to signs of hypercorticism (e.g., Cushingoid features, adrenal suppression).
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. For advice, call a poison control center at 1-800-222-1222. Treatment is supportive and symptomatic. Monitor cardiac function and serum potassium levels.
Drug Interactions
Contraindicated Interactions
- Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, telithromycin, nefazodone) due to increased systemic exposure of fluticasone and salmeterol, leading to increased risk of cardiovascular and systemic corticosteroid adverse effects.
Major Interactions
- Beta-blockers (especially non-selective): May block the bronchodilatory effect of salmeterol and cause severe bronchospasm in patients with asthma. Use with caution and only if no suitable alternative.
- Other long-acting beta2-agonists (LABAs): Concomitant use is not recommended as it may lead to overdose of LABA.
- Diuretics (loop or thiazide): May potentiate ECG changes and/or hypokalemia associated with beta-agonists, especially at high doses.
- Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs): May potentiate the cardiovascular effects of salmeterol (e.g., arrhythmias, hypertension). Use with extreme caution or avoid within 2 weeks of discontinuing MAOIs.
Moderate Interactions
- Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil): May increase systemic exposure of fluticasone and salmeterol, requiring caution and monitoring.
- Other sympathomimetics: Concomitant use may potentiate adverse cardiovascular effects.
Minor Interactions
- Not specifically listed as minor interactions; most interactions are significant due to the nature of the active ingredients.
Monitoring
Baseline Monitoring
Rationale: To establish baseline lung function and assess disease severity.
Timing: Prior to initiation of therapy.
Rationale: To evaluate baseline symptom frequency, severity, and impact on daily life.
Timing: Prior to initiation of therapy.
Rationale: To assess for potential adrenal suppression.
Timing: Prior to or during transition from systemic corticosteroids.
Routine Monitoring
Frequency: Regularly (e.g., at each follow-up visit, patient self-monitoring daily)
Target: Minimal symptoms, infrequent rescue inhaler use, no nocturnal awakenings.
Action Threshold: Worsening symptoms, increased rescue inhaler use, nocturnal awakenings, decreased peak flow readings.
Frequency: Periodically (e.g., every 3-12 months for stable patients, more frequently if unstable)
Target: Improvement or maintenance of lung function.
Action Threshold: Significant decline in FEV1.
Frequency: Regularly (e.g., every 3-6 months)
Target: Normal growth velocity.
Action Threshold: Growth retardation.
Frequency: At each visit, patient self-monitoring daily
Target: Absence of white patches in mouth/throat.
Action Threshold: Presence of white patches, soreness.
Frequency: Periodically, especially with higher doses or prolonged use
Target: Absence of signs/symptoms.
Action Threshold: Development of signs/symptoms.
Frequency: Annually for patients at risk or on long-term therapy
Target: Normal intraocular pressure, absence of cataracts.
Action Threshold: Increased intraocular pressure, vision changes.
Frequency: As needed, especially with high doses or concomitant diuretics
Target: Normal ranges.
Action Threshold: Hypokalemia, hyperglycemia.
Symptom Monitoring
- Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
- Increased frequency of rescue inhaler use
- Decreased peak expiratory flow (PEF) readings
- Nocturnal awakenings due to respiratory symptoms
- Signs of oral candidiasis (white patches in mouth/throat)
- Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain)
- Paradoxical bronchospasm (immediate worsening of breathing after inhalation)
- Cardiovascular symptoms (e.g., palpitations, chest pain, rapid heart rate, tremor)
- Signs of infection (e.g., fever, increased sputum production, change in sputum color)
Special Patient Groups
Pregnancy
Advair HFA should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Uncontrolled asthma in pregnancy poses a greater risk to both mother and fetus than the potential risks of medication. There are no adequate and well-controlled studies in pregnant women. Animal studies have shown teratogenic effects with high doses of fluticasone and salmeterol.
Trimester-Specific Risks:
Lactation
It is not known whether fluticasone propionate or salmeterol xinafoate are excreted in human breast milk. However, other corticosteroids and beta2-agonists are excreted. Caution should be exercised when Advair HFA is administered to a nursing mother. The developmental and health benefits of breastfeeding should be considered along with the motherβs clinical need for Advair HFA and any potential adverse effects on the breastfed infant from Advair HFA or from the underlying maternal condition.
Pediatric Use
Advair HFA is approved for asthma in patients 12 years of age and older. Safety and effectiveness in children younger than 12 years have not been established. Monitor growth velocity in pediatric patients receiving inhaled corticosteroids, as they may cause a reduction in growth rate.
Geriatric Use
No dosage adjustment is required based on age. However, elderly patients may be more susceptible to the cardiovascular effects of beta2-agonists and may have age-related decreases in hepatic or renal function, which could affect drug clearance. Monitor for comorbidities and potential drug interactions.
Clinical Information
Clinical Pearls
- Advair HFA is a maintenance medication and should not be used for acute bronchospasm. Patients should always have a rescue inhaler available.
- Proper inhaler technique is critical for drug delivery and efficacy. Patients should be instructed and regularly re-evaluated on their technique.
- Rinsing the mouth with water and spitting after each dose helps prevent oral candidiasis (thrush).
- Patients should be advised not to stop Advair HFA abruptly, especially if they have been on high doses or for prolonged periods, due to the risk of adrenal insufficiency.
- Monitor for signs of pneumonia in COPD patients, as ICS use may increase this risk.
- Patients should be aware of the Black Box Warning regarding LABAs and asthma-related death, but also understand that the combination with an ICS mitigates this risk for asthma patients.
Alternative Therapies
- Inhaled Corticosteroid (ICS) monotherapy (e.g., fluticasone propionate, budesonide)
- Long-Acting Muscarinic Antagonist (LAMA) monotherapy (e.g., tiotropium, umeclidinium) for COPD
- Short-Acting Beta2-Agonists (SABAs) for rescue (e.g., albuterol)
- Leukotriene Receptor Antagonists (LTRAs) (e.g., montelukast)
- Oral corticosteroids (for severe exacerbations or refractory disease)